Tuning charge density of chimeric antigen receptor optimizes tonic signaling and CAR-T cell fitness

Jian Chen(ShanghaiTech University), Shizhen Qiu(ShanghaiTech University), Wentao Li(Austrian Academy of Sciences), Kun Wang(ShanghaiTech University), Yu Zhang(Center for Excellence in Molecular Cell Science), Han Kwang Yang(ShanghaiTech University), Baichuan Liu(ShanghaiTech University), Guangfei Li(Eye & ENT Hospital of Fudan University), Li Li(ShanghaiTech University), Min Chen(Eye & ENT Hospital of Fudan University), Junjie Lan(Xiamen Institute of Building Research Group), Jiahua Niu(Shanghai First People's Hospital), Peijie He(Eye & ENT Hospital of Fudan University), Lei Cheng(Eye & ENT Hospital of Fudan University), Gaofeng Fan(ShanghaiTech University), Xin Liu(Center for Excellence in Molecular Cell Science), Xianmin Song(Shanghai Jiao Tong University), Chenqi Xu(Center for Excellence in Molecular Cell Science), Haitao Wu(Eye & ENT Hospital of Fudan University), Haopeng Wang(ShanghaiTech University)
Cell Research
March 8, 2023
Cited by 161Open Access
Full Text

Abstract

Tonic signaling of chimeric antigen receptor (CAR), i.e., the spontaneous CAR activation in the absence of tumor antigen stimulation, is considered to be a pivotal event controlling CAR-T efficacy. However, the molecular mechanism underlying the spontaneous CAR signals remains elusive. Here, we unveil that positively charged patches (PCPs) on the surface of the CAR antigen-binding domain mediate CAR clustering and result in CAR tonic signaling. For CARs with high tonic signaling (e.g., GD2.CAR and CSPG4.CAR), reducing PCPs on CARs or boosting ionic strength in the culture medium during ex vivo CAR-T cell expansion minimizes spontaneous CAR activation and alleviates CAR-T cell exhaustion. In contrast, introducing PCPs into the CAR with weak tonic signaling, such as CD19.CAR, results in improved in vivo persistence and superior antitumor function. These results demonstrate that CAR tonic signaling is induced and maintained by PCP-mediated CAR clustering. Notably, the mutations we generated to alter the PCPs maintain the antigen-binding affinity and specificity of the CAR. Therefore, our findings suggest that the rational tuning of PCPs to optimize tonic signaling and in vivo fitness of CAR-T cells is a promising design strategy for the next-generation CAR.


Related Papers

No related papers found

Powered by citation graph analysis